[Immunosuppressive therapy in hematology].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000741:Anemia, Aplastic / Q000188:drug therapy / Q000276:immunology; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000750:Anemia, Myelophthisic / Q000188:drug therapy / Q000276:immunology; D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D001323:Autoantibodies; D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy*; D002699:Chlorambucil / Q000627:therapeutic use; D006457:Hemoglobinuria, Paroxysmal / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents; D007970:Leukopenia / Q000188:drug therapy / Q000276:immunology; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000276:immunology; D012075:Remission, Spontaneous; D013921:Thrombocytopenia / Q000276:immunology
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D001215:Asparaginase; D010396:Penicillamine
Immunsuppressive Therapie in der Hämatologie.